Unveiling the impact of COVID-19 on diabetics: vaccination status and infection rates in a North Indian state-insights from a primary healthcare centre-based non-communicable disease registry
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20240280Keywords:
Diabetes mellitus, COVID-19, COVID-19 vaccinationAbstract
Background: Patients with diabetes are at an increased risk of severe infection and mortality due to COVID-19. Absence of effective pharmacological treatments, vaccination remains one of the most effective means of controlling the pandemic. Our study aims to investigate the prevalence of COVID-19 infection among patients with diabetes mellitus and assess the coverage of COVID-19 vaccination among these patients.
Methods: The patients were identified from a primary healthcare centre (PHC) based non-communicable disease (NCD) registry at PHC Najafgarh, New Delhi. A total of 480 patients were included in this study. The data was retrieved from NCD registry and vaccination status was confirmed from their vaccination certificates.
Results: In our study 91.3% (438) of diabetic patients had received the first dose of COVID-19 vaccine and the coverage for second dose and third dose among these same patients are 84.6% and 27.3% respectively.
Conclusions: Only a quarter of all the patients have received precautionary dose (3rd dose), and almost a tenth of all the patients have not even received a single dose of COVID-19 vaccine, the patients should be counselled and encouraged for vaccination. Also, it is recommended to take COVID-19 vaccination into consideration while taking the medical history of diabetics.
References
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/. Accessed on 09 February 2023.
Ministry of Health & Family Welfare, Govt, of India. Available at: https://www.mohfw.gov.in/. Accessed on 09 February 2023.
International Diabetes Federation. Available at: https://idf.org/. Accessed on 09 February 2023.
Nath R, Gupta NK, Jaswal A, Gupta S, Kaur N, Kohli S, et al. Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India. Monaldi Arch Chest Dis. 2021;92(2).
Agrawal S, Nath R, Ish P, Gupta NK, Gaind R, Kale S, et al. Clinico-epidemiological profile of COVID-19 patients admitted during third wave of pandemic in a tertiary care hospital in New Delhi, India. Monaldi Arch Chest Dis. 2022;93(2).
Sandooja C, Kishore J, Debnath A, Ahmad A. Perception and Attitude Towards COVID-19 Vaccination Among the Elderly: A Community-Based Cross-Sectional Study. Cureus. 2022;14(12):e33108.
Nachimuthu S, Viswanathan V. Trend in COVID-19 vaccination among people with diabetes: A short study from India. Diabetes Metab Syndr. 2021;15(4):102190.
Tourkmani AM, Bin Rsheed AM, AlEissa MS, Alqahtani SM, AlOtaibi AF, Almujil MS, et al. Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry. Vaccines. 2022;10(2):310.
Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-10.
Yang Y, Zou S, Xu G. An update on the interaction between COVID-19, vaccines, and diabetic kidney disease. Front Immunol. 2022;13:999534.
Duan L, Wang Y, Dong H, Song C, Zheng J, Li J, et al. The COVID-19 Vaccination Behavior and Correlates in Diabetic Patients: A Health Belief Model Theory-Based Cross-Sectional Study in China, 2021. Vaccines. 2022;10(5):659.
